BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• joimax Revolutionizes Spine Surgery With the Launch of Newest and Fully-Endoscopic Product Innovations to Treat Spinal Canal Stenosis

  June 3, 2008

   · 

  3 min read
• BioCapital

  Multiple Independent Studies Report on Use of Cylex, Inc.'s Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients To Be Presented at the Annual American Transplant Congress

  June 3, 2008

   · 

  2 min read
• FDA

  Xenobiotic Detection Systems (XDS) and University of California, Davis (UCD) Release: EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435

  June 3, 2008

   · 

  2 min read
• Drug Development

  New Data For Pazopanib - GlaxoSmithKline’s Latest Investigational Anti-Cancer Agent - Shows Promise Across Multiple Cancers

  June 3, 2008

   · 

  11 min read
• Drug Development

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Release: Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma

  June 3, 2008

   · 

  10 min read
• Drug Development

  Cell Therapeutics, Inc. Release: Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin’s Lymphoma

  June 3, 2008

   · 

  5 min read
• Drug Development

  EntreMed, Inc.'s ENMD-2076 Demonstrates Antitumor Activity in Multiple Myeloma Model; Preclinical Data Support Rationale for Clinical Study

  June 3, 2008

   · 

  4 min read
• Drug Development

  Genta Incorporated Announces Initial Clinical Trial Results for G4544, a Novel Potent Drug for Bone Disease

  June 3, 2008

   · 

  4 min read
• Pharm Country

  MDS Pharma Services Adopts Innovative Technology for Bioanalysis Electrochemiluminescent Assay (ECLA)

  June 3, 2008

   · 

  2 min read
• Biotech Bay

  Genomic Health, Inc. Announces Expansion of Oncotype DX(R) Breast Cancer Test to Include Quantitative Estrogen Receptor (ER) and Progesterone Receptor (PR) Scores

  June 3, 2008

   · 

  5 min read